Copertina

Bone marrow niches for hematopoietic stem cells

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ana Luísa Pereira, Serena Galli, César Nombela‐Arrieta
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	HemaSphere
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

TET3 regulates hematopoietic stem cell homeostasis during embryonic and adult hematopoiesis
di: Harmony C. Ketchum, et al.
Pubblicazione: (2025)

Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
di: Baptiste Le Calvez, et al.
Pubblicazione: (2024)

HLA evolutionary divergence score after donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
di: Sophie Le Grand, et al.
Pubblicazione: (2025)

Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early‐life DNMT3A mutations
di: Lucca L. M. Derks, et al.
Pubblicazione: (2025)

Correction to “Posttransplantation clonal dynamics of hematopoietic stem cells carrying prenatal and early‐life DNMT3A mutations”
Pubblicazione: (2026)

Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia
di: Kyung Taek Hong, et al.
Pubblicazione: (2024)

Time‐restricted versus standard‐duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON‐96 trial
di: Annoek E. C. Broers, et al.
Pubblicazione: (2024)

A single JAK2 ‐V617F hematopoietic stem cell can initiate myeloproliferative neoplasm when transplanted into non‐conditioned recipient mice
di: Quentin Kimmerlin, et al.
Pubblicazione: (2026)

Models for the marrow: A comprehensive review of AI‐based cell classification methods and malignancy detection in bone marrow aspirate smears
di: Tabita Ghete, et al.
Pubblicazione: (2024)

Definitions matter: Multicenter investigation of incidence and outcome of poor graft function after hematopoietic cell transplantation
di: Konradin F. Müskens, et al.
Pubblicazione: (2024)

Long‐term outcome of 2‐year survivors after allogeneic hematopoietic cell transplantation for acute leukemia
di: Marion Larue, et al.
Pubblicazione: (2024)

Inhibiting the alarmin‐driven hematopoiesis‐stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis
di: Hélène F. E. Gleitz, et al.
Pubblicazione: (2025)

Who owns that blood? Recontacting donors with results from genetic testing after allogeneic hematopoietic cell transplantation
di: Mirjam E. Belderbos, et al.
Pubblicazione: (2025)

From hypoxia single‐cell gene signatures to HIF targeting of AML leukemic stem cells
di: Thomas Mercher, et al.
Pubblicazione: (2024)

IDALLO study: A retrospective multicenter study of the SFGM‐TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1‐mutated AML after allogeneic hematopoietic cell transplantation
di: Adrien Caillet, et al.
Pubblicazione: (2024)

Correction to “Influence of donor–recipient sex on engraftment of normal and leukemia stem cells in xenotransplantation”
Pubblicazione: (2024)

3D Tumor microenvironment interaction reveals AP‐1 complex regulation and contact‐mediated reprogramming of bone marrow stromal cells in chronic lymphocytic leukemia
di: Jana Lindacher, et al.
Pubblicazione: (2025)

Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed‐methods, prospective cohort study
di: Elisabeth Dovern, et al.
Pubblicazione: (2025)

Autologous stem cell transplantation in NK/T‐cell lymphoma: Prognostic impact of EBV‐DNA in a multinational cohort—A study by the EBMT Lymphoma Working Party
di: Philipp Berning, et al.
Pubblicazione: (2025)

Impact of second autologous stem‐cell transplantation at relapsed multiple myeloma: A French multicentric real‐life study
di: Axel André, et al.
Pubblicazione: (2024)

Persistent BCR::ABL1 ‐positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome‐positive ALL
di: Jean‐Edouard Martin, et al.
Pubblicazione: (2026)

Early peripheral blood and bone marrow MRD as prognostic markers in quadruplet‐treated multiple myeloma without transplant
di: Benjamin A. Derman, et al.
Pubblicazione: (2025)

How to diagnose acid sphingomyelinase deficiency (ASMD) and Niemann–Pick disease type C from bone marrow and peripheral blood smears
di: Sandrine Girard, et al.
Pubblicazione: (2024)

The role of trephine bone marrow biopsies in the era of measurable residual disease — Results from the CLL10 trial of the German CLL Study Group (GCLLSG)
di: Nadine Kutsch, et al.
Pubblicazione: (2024)

Chimeric antigen receptor T‐cell therapy outcomes in T cell/histiocyte‐rich large B‐cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
di: Mariana Bastos‐Oreiro, et al.
Pubblicazione: (2025)

The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300‐dependent stemness program
di: Alexandre Fagnan, et al.
Pubblicazione: (2024)

Delving deeper into the pathogenesis and genomics of posttransplant diffuse large B‐cell lymphoma
di: Flore Sneyers, et al.
Pubblicazione: (2025)

Treatment outcomes in patients with large B‐cell lymphoma after progression to chimeric antigen receptor T‐cell therapy
di: Gloria Iacoboni, et al.
Pubblicazione: (2024)

Lower efficacy of transfusion of red blood cells from donors with sickle cell trait
di: Monika Dzieciatkowska, et al.
Pubblicazione: (2026)

Fetal‐hemoglobin‐expressing red blood cells (“F cells”) consist of three distinct types as revealed by single‐cell transcriptomic analysis of circulating reticulocytes
di: Helen Rooks, et al.
Pubblicazione: (2025)

Correction to “Single‐cell RNA sequencing of pediatric Hodgkin lymphoma to study the inhibition of T cell subtypes”
Pubblicazione: (2024)

Iron, arginine, and redox metabolism in peripheral blood mononuclear cells distinguishes sickle cell disease and pulmonary hypertension
di: Francesca I. Cendali, et al.
Pubblicazione: (2026)

Prognostic significance of immune reconstitution following CD19 CAR T‐cell therapy for relapsed/refractory B‐cell lymphoma
di: Sophia Stock, et al.
Pubblicazione: (2025)

Folate receptor beta targeting of tumor‐associated macrophages improves lymphoma cell responses to CD19 CAR T cells
di: Kerttu Kalander, et al.
Pubblicazione: (2026)

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B‐cell lymphoma
di: André Airosa Pardal, et al.
Pubblicazione: (2025)

Mitochondrial retention in mature red blood cells from patients with sickle cell disease is associated with stress erythropoiesis but not with proinflammatory state
di: Marc Romana, et al.
Pubblicazione: (2024)

Outcomes and treatment patterns of patients with primary mediastinal B‐cell lymphoma after CAR‐T cell therapy failure: A DESCAR‐T analysis
di: Jean Galtier, et al.
Pubblicazione: (2025)

Impact of the kinetics of circulating anti‐BCMA CAR‐T cells and normal lymphocytes on the outcome of MM patients
di: Sara Gutiérrez‐Herrero, et al.
Pubblicazione: (2025)

Efficacy and safety of bendamustine‐containing bridging therapy in R/R LBCL patients receiving CD19 CAR T‐cells
di: Gloria Iacoboni, et al.
Pubblicazione: (2024)

Varnimcabtagene autoleucel (ARI‐0001) in relapsed or refractory mantle cell lymphoma
di: Nil Albiol, et al.
Pubblicazione: (2026)